Evaluation of Pirfenidone and Nintedanib in a Human Lung Model of Fibrogenesis

Overview of attention for article published in Frontiers in Pharmacology, October 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

So far, Altmetric has seen 19 X posts from 15 X users, with an upper bound of 21,124 followers.

New article: Evaluation of Pirfenidone and Nintedanib in a Human Lung Model of Fibrogenesis https://t.co/M0jEgiZ67Z #lungcancer #oncology https://t.co/MwGjHe3p88

RT @drkatyroach: Our new paper provides novel data regarding the molecular effects of current IPF therapies in a human lung tissue model of…

RT @drkatyroach: Our new paper provides novel data regarding the molecular effects of current IPF therapies in a human lung tissue model of…

RT @drkatyroach: Our new paper provides novel data regarding the molecular effects of current IPF therapies in a human lung tissue model of…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 15 additional X posts.